Sunshine Biopharma Inc. (SBFM)
2.27
-0.02 (-0.87%)
At close: Mar 03, 2025, 3:59 PM
2.31
1.76%
After-hours: Mar 03, 2025, 04:00 PM EST
Sunshine Biopharma Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Revenue | 24.09M | 4.35M | 228.43K | 71.41K | 21.12K | 447.2K | n/a | n/a | 1.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 15.75M | 2.65M | 117.83K | 25.85K | 11.05K | 391.08K | 6.63K | 60.73K | 384.58K | 263.33K | 475K | 250K | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 8.34M | 1.7M | 110.6K | 45.56K | 10.07K | 56.12K | -6.63K | -60.73K | -382.87K | -263.33K | -475K | -250K | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -4.79M | -8.67M | -2.44M | -576.87K | -641.64K | -1.17M | -857.19K | -993.11K | -780.28K | -1.76M | -1.94M | -706.68K | -556.2K | -537.38K | -15.65K | -26.08K | -13.12K |
| Interest Income | 811.97K | 518.65K | 328.82K | 168.1K | 115.9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -4.11M | -26.51M | -12.44M | -2.78M | -1.08M | -2.16M | -1.04M | -3.5M | -1.65M | -1.93M | -2.49M | -707.95K | n/a | -537.38K | n/a | n/a | n/a |
| Net Income | -4.51M | -26.74M | -12.77M | -897.68K | -1.46M | -2.16M | -1.04M | -3.5M | -1.65M | -1.93M | -2.49M | -707.95K | -556.2K | -537.38K | n/a | -31.11K | -13.12K |
| Selling & General & Admin | 10.83M | 9.48M | 1.87M | 547.42K | 622.73K | 1.21M | 850.56K | 899.58K | 769.08K | 1.43M | 1.8M | 704.85K | 413.55K | 537.38K | 20.00 | 26.08K | 13.12K |
| Research & Development | 1.86M | 811.86K | 672.21K | 60.95K | 15.2K | 12.8K | n/a | 32.79K | 8.66K | 327K | 137.4K | 1.83K | 142.65K | n/a | n/a | n/a | n/a |
| Other Expenses | 438.88K | 80.4K | 12.74K | 14.07K | 13.77K | -871.73K | -76.93K | 60.73K | 4.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 13.12M | 10.37M | 2.55M | 622.44K | 651.71K | 1.22M | 857.19K | 993.11K | 781.99K | 1.76M | 1.94M | 706.68K | 556.2K | 537.38K | 20.00 | 26.08K | 13.12K |
| Interest Expense | 137.31K | 39.41K | 328.82K | 168.1K | 115.9K | 159.42K | 104.83K | 34.73K | 307.21K | 179.1K | 6.46K | 1.27K | n/a | n/a | n/a | 5.03K | -13.12K |
| Selling & Marketing Expenses | 734.25K | 578.09K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 105K | n/a | n/a | n/a | n/a | 20.00 | 2K | n/a |
| Cost & Expenses | 28.88M | 13.02M | 2.67M | 648.28K | 662.76K | 1.61M | 857.19K | 993.11K | 781.99K | 1.76M | 1.94M | 706.68K | 556.2K | 537.38K | 20.00 | 26.08K | 13.12K |
| Income Tax | 395.17K | 233.3K | 328.82K | -1.89M | 383.39K | -41.53K | 1.29K | 2.47M | 565.42K | -1.75M | 548.95K | -703.39K | 556.2K | n/a | n/a | 31.11K | 13.12K |
| Shares Outstanding (Basic) | 12.16K | 7.59K | 1.31K | 866.00 | 1.76K | 15.23K | 43.63K | 21.24K | 1.53K | 3.68K | 3.01K | 2.57K | 2.44K | 1.53K | 23.47K | 468.00 | 468.00 |
| Shares Outstanding (Diluted) | 12.16K | 7.59K | 1.31K | 866.00 | 1.76K | 15.23K | 43.63K | 21.24K | 1.53K | 3.68K | 3.01K | 2.57K | 2.44K | 1.53K | 23.47K | 468.00 | 468.00 |
| EPS (Basic) | -370.41 | -3.52K | -9.77K | -1.04K | -828.01 | -141.54 | -23.84 | -164.63 | -270.44 | -526.17 | -827.19 | -275.68 | -228.33 | -350.77 | n/a | -66.46 | -28.04 |
| EPS (Diluted) | -370.41 | -3.52K | -9.77K | -1.04K | -828.01 | -141.54 | -23.84 | -164.63 | -270.44 | -526.17 | -827.19 | -275.68 | -228.33 | -350.77 | n/a | -66.46 | -28.04 |
| EBITDA | -3.82M | -26.45M | -12.09M | -2.6M | -948.38K | -1.95M | -928.78K | -932.38K | -1.34M | -9.77K | -555.03K | -4.56K | -556.2K | -537.38K | -1.2M | -26.08K | -13.12K |
| Depreciation & Amortization | 149.15K | 25.16K | 12.74K | 14.07K | 13.77K | 49.36K | 6.63K | 60.73K | 4.25K | 1.75M | 1.93M | 703.39K | n/a | n/a | n/a | n/a | n/a |